Foghorn Therapeutics Inc. at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Hi, good morning. I'm Paul Choi, SMid-cap Biotechnology Analyst at Goldman Sachs, and I'd like to welcome everyone listening here on the webcast to the 42nd Annual Goldman Sachs Global Healthcare Conference. We have prepared to read disclosures out loud, but they are available here through the webcast here; or, alternatively, on the Goldman Sachs research portal.
And with that, we'll kick off our first session, which is with Foghorn Therapeutics. And with us is CEO, Adrian Gottschalk. Adrian, welcome.
Good morning, Paul. Nice to be here with you. Thanks for having me.
Great. Thank you, Adrian. So what we'll do and kick it off is this Q&A, and as always, investors can email me directly, or through the webcam portal, submit questions if they have them. And time permitting, I will read them out loud to Adrian to respond to.
But
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
